Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qixun Chen

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2024
Reply to: "Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy"Jifeng Feng, Qixun Chen
Annals of Surgical Oncology|February 23, 2024
Reply to Letter to the Editor Regarding "Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?"Jifeng Feng, Qixun Chen
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2024
Reply to: Unlocking the potential of the geriatric nutritional risk indicator in predicting outcomes of neoadjuvant immunotherapy for esophageal cancerJifeng Feng, Qixun Chen
Translational Cancer Research|February 4, 2022
Analysis of lymph node metastasis in 200 patients with non-small cell lung cancerTaobo Luo, Qixun Chen, Jian Zeng
Frontiers in Immunology|January 1, 2025
Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Bosnian Journal of Basic Medical Sciences|October 22, 2021
Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
World Journal of Surgical Oncology|August 28, 2012
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?Yaping Xu, Xinmin Yu, Qixun Chen, et al.
Frontiers in Immunology|October 3, 2025
Serum creatinine to cystatin C ratio is a prognostic indicator in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|February 17, 2025
The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
The Journal of Obstetrics and Gynaecology Research|October 9, 2023
Pulmonary metastasectomy for recurrent metastatic ovarian cancerFeng Cheng, Junjian Wang, Qixun Chen, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2024
Reply to: "Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy"Jifeng Feng, Qixun Chen
Annals of Surgical Oncology|February 23, 2024
Reply to Letter to the Editor Regarding "Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?"Jifeng Feng, Qixun Chen
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2024
Reply to: Unlocking the potential of the geriatric nutritional risk indicator in predicting outcomes of neoadjuvant immunotherapy for esophageal cancerJifeng Feng, Qixun Chen
Translational Cancer Research|February 4, 2022
Analysis of lymph node metastasis in 200 patients with non-small cell lung cancerTaobo Luo, Qixun Chen, Jian Zeng
Frontiers in Immunology|January 1, 2025
Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Bosnian Journal of Basic Medical Sciences|October 22, 2021
Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
World Journal of Surgical Oncology|August 28, 2012
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?Yaping Xu, Xinmin Yu, Qixun Chen, et al.
Frontiers in Immunology|October 3, 2025
Serum creatinine to cystatin C ratio is a prognostic indicator in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|February 17, 2025
The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
The Journal of Obstetrics and Gynaecology Research|October 9, 2023
Pulmonary metastasectomy for recurrent metastatic ovarian cancerFeng Cheng, Junjian Wang, Qixun Chen, et al.
Pageof 9